InspireMD is a medical device company headquartered in Tel Aviv, Israel, specializing in the development and commercialization of its proprietary MicroNet stent platform technology for treating vascular and coronary diseases. The company offers products such as the CGuard carotid embolic prevention system, designed for carotid artery applications, and the MGuard Prime embolic protection system, intended for patients with acute coronary syndromes. InspireMD is also working on the NGuard neurovascular flow diverter, which aims to divert blood flow away from cerebral aneurysms. The company generates most of its revenue from the sales of the CGuard system, which integrates MicroNet technology with a self-expandable nitinol stent. Its products are distributed through local partners in various regions, including Europe, Latin America, the Middle East, and Asia.
Prognos Health is a prominent health tech company specializing in healthcare analytics aimed at improving disease management and treatment decision-making. Its platform, prognosFACTOR, allows users to quickly query billions of lab and health records from over 325 million de-identified patients, significantly reducing the time needed to answer critical healthcare questions. The Prognos Registry serves as the largest source of clinical diagnostics information across more than 30 disease areas, encompassing over 5 billion medical records for 100 million patients. By employing a suite of 500 proprietary clinical algorithms, Prognos facilitates earlier patient identification, enhancing treatment decisions and risk management. The company collaborates with key stakeholders in the healthcare ecosystem, including pharmaceutical manufacturers and payers, providing HIPAA-compliant patient-centric data through the Prognos Marketplace for various applications such as cohort design and health outcomes analysis.
Acelyrin is a late-stage clinical biopharmaceutical company dedicated to delivering innovative treatment options to patients. The company specializes in identifying, acquiring, and accelerating the development and commercialization of promising drug candidates. By leveraging its expertise, Acelyrin aims to advance transformative medicines that can significantly improve patient outcomes.
Amun is a technology company that creates financial on-ramps to acquire, trade, and secure crypto assets. Individual customers and institutions can use our products to get crypto exposure in a safe, regulated, and easy manner.
Developer of a drug delivery platform intended to improve subcutaneous administration. The company's formulation system can effectively process a wide range of therapeutic molecules and its technology can process large, increasingly complex, and delicate proteins including monoclonal antibodies, and bispecific, and fusion proteins, enabling drug manufacturers to develop breakthrough therapies easily by giving patients the ability to control how they want to receive and benefit from life-changing medicines.
Turtlemint is an online insurance platform that identifies and purchases appropriate insurance policies for consumers. It aims to “demystify” insurance by explaining the jargon in a simple way and providing smart tools to help a user make the right choice. From search to purchase, the entire process can be completed online in just a few clicks. The company offers car insurance, bike insurance, health insurance, and term life insurance. It was founded in 2015 and is based in Mumbai, Maharashtra, India.
Private Equity Round in 2022
Circle is a financial technology company that leverages blockchain technology to facilitate the sending, receiving, and investing of cryptocurrency assets globally. Founded in 2013 by Jeremy Allaire and Sean Neville, Circle offers a user-friendly online platform that simplifies money transfers and includes services such as Circle Pay for peer-to-peer payments. In addition, the company provides Circle Invest, allowing users to buy and sell cryptocurrencies, and Circle Trade, which operates a trading desk with a substantial liquidity pool for digital assets, averaging $2 billion in monthly trading volume. With significant backing from investors, including notable firms such as Goldman Sachs and Accel Partners, Circle has established a presence in major cities, including Boston, New York, San Francisco, Dublin, London, and Hong Kong. The company is dedicated to accelerating global crypto innovation and adoption through its various financial services.
Parse Biosciences, based in Seattle, Washington, focuses on single-cell analysis and was incorporated in 2018. The company is dedicated to developing innovative technologies that enhance the understanding of cellular diversity and function at the single-cell level. By leveraging advanced methodologies, Parse Biosciences aims to provide researchers with powerful tools for exploring complex biological systems, ultimately advancing the fields of genomics and biomedical research.
ConsenSys is a leading blockchain venture production studio focused on building a robust ecosystem of consumer-oriented products and enterprise solutions, primarily utilizing Ethereum technology. The company aims to facilitate the transition to Web 3.0, which it envisions as a foundation for more open, efficient, and accessible economic systems. ConsenSys identifies opportunities for software development and promotes collaboration among various ventures to enhance innovation and idea exchange. By creating platforms, applications, and tools that support Web 3.0, ConsenSys strives to ensure these solutions effectively meet customer needs. The organization also collaborates with blockchain experts and partners to develop open infrastructure, positioning itself at the forefront of technological advancements that have the potential to disrupt various industries.
Metagenomi, Inc. is a genetic medicines company based in Emeryville, California, focused on developing innovative gene editing systems for the treatment of genetic diseases. Since its incorporation in 2016, the company has utilized a proprietary metagenomics-derived genome editing toolbox that enables the creation of curative therapeutics. This toolbox encompasses a range of advanced technologies, including programmable nucleases, base editors, and various RNA and DNA-mediated integration systems, such as prime editing systems and CRISPR-associated transposases (CASTs). Metagenomi aims to address the challenges posed by diverse mutations that have traditionally been difficult to target with existing genome engineering approaches.
Lukka is a leading technology and data services provider for middle and back-office crypto asset processing. Its crypto-native products connect, standardize, reconcile, process, and report audit-ready information within a highly secure SOC 1 Type 2 enterprise-grade infrastructure. Lukka was founded in 2014 and headquartered in New York, United States.
Private Equity Round in 2022
Accelerant Holdings Ltd. is a wholesale insurance managing general agent (MGA) that primarily serves the small and medium-sized enterprise (SME) market. Founded in 2018 and headquartered in London, United Kingdom, the company operates as an underwriting group, focusing on a carefully selected and managed network of members. By providing tailored insurance solutions, Accelerant aims to address the unique needs of SMEs, fostering a strong support system within this sector.
Tipalti, Inc. is a provider of accounts payable automation and global mass payments software, designed to streamline payment processes for businesses. Founded in 2010 and headquartered in San Mateo, California, with an additional office in Kibbutz Glil-Yam, Israel, Tipalti offers a comprehensive cloud-based solution that manages the entire payables workflow. This includes supplier onboarding and management, tax compliance, invoice processing, global funds disbursement, and payment reconciliation. The platform is particularly beneficial for sectors such as ad networks, affiliate networks, ecommerce, and online marketplaces, allowing companies to significantly reduce their supplier payment workload by up to 80%. By automating these processes, Tipalti helps businesses scale efficiently while maintaining financial and regulatory compliance, ultimately enhancing the experience for partners and suppliers.
TRM Labs Inc. is a regulatory technology startup based in San Francisco, California, founded in 2017. The company operates a token relationship management platform that utilizes machine learning to assist clients in managing customer relationships and identifying suspicious activities, such as money laundering and market manipulation. Its offerings include on-chain anti-money laundering compliance, customer due diligence, and transaction monitoring solutions tailored for digital asset companies. Additionally, TRM Labs develops enterprise applications and developer tools that facilitate the launch of blockchain-based products, enhancing compliance and risk management in the cryptocurrency industry. By streamlining compliance processes, TRM Labs aims to foster a secure environment for value exchange within the digital asset space.
ConsenSys is a leading blockchain venture production studio focused on building a robust ecosystem of consumer-oriented products and enterprise solutions, primarily utilizing Ethereum technology. The company aims to facilitate the transition to Web 3.0, which it envisions as a foundation for more open, efficient, and accessible economic systems. ConsenSys identifies opportunities for software development and promotes collaboration among various ventures to enhance innovation and idea exchange. By creating platforms, applications, and tools that support Web 3.0, ConsenSys strives to ensure these solutions effectively meet customer needs. The organization also collaborates with blockchain experts and partners to develop open infrastructure, positioning itself at the forefront of technological advancements that have the potential to disrupt various industries.
Acelyrin is a late-stage clinical biopharmaceutical company dedicated to delivering innovative treatment options to patients. The company specializes in identifying, acquiring, and accelerating the development and commercialization of promising drug candidates. By leveraging its expertise, Acelyrin aims to advance transformative medicines that can significantly improve patient outcomes.
Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on developing oncology medicines tailored to individual patients. The company employs a proteomics-based platform to identify patients whose tumors are likely to respond to specific treatments, thereby enhancing the effectiveness of drug development. Acrivon's lead program is ACR-368, also known as prexasertib, which is currently in Phase 2 trials. Additionally, the pipeline includes preclinical programs that target critical components of the DNA Damage Response and cell cycle regulation pathways, specifically focusing on proteins such as WEE1 and PKMYT1. By leveraging these innovative approaches, Acrivon aims to improve therapeutic outcomes for cancer patients.
Vayana Network is a financing network that enables Businesses and their Trade Partners to capture their entire receivable and payable trades electronically and finance through Banks and Financial Institutions. Businesses can finance their payables, or factor their receivables or make financing available to their counterparties. Vayana Network, in partnership with MasterCard and Banks, also offers its award winning Commercial Card solution for Payable financing.
CRED is a members-only app that rewards the user with exclusive rewards for paying credit card bills. The company is committed to protecting the data and information of its members. CRED works on the guiding principle of opt-In consent and full transparency. The company's security processes and technology implementations combined with regulatory compliance is how it access, store, and use member data.
Varo Money, Inc. is a digital bank based in San Francisco, California, that offers a range of online banking products and services, including bank and savings accounts, checking accounts, and overdraft protection. Established in 2015 and known for being the only U.S. consumer fintech with a national bank charter, Varo aims to serve as a comprehensive banking partner for millions of Americans, especially those seeking better financial solutions. The company combines fintech innovation with the security of a chartered bank, providing tools and insights to enhance financial resilience for its customers. Varo's platform also includes features such as spending analysis, real-time budgeting, cash flow forecasts, direct deposits, and online bill payments, all designed to empower users to make informed financial decisions and improve their overall financial well-being.
Varo Money, Inc. is a digital bank based in San Francisco, California, that offers a range of online banking products and services, including bank and savings accounts, checking accounts, and overdraft protection. Established in 2015 and known for being the only U.S. consumer fintech with a national bank charter, Varo aims to serve as a comprehensive banking partner for millions of Americans, especially those seeking better financial solutions. The company combines fintech innovation with the security of a chartered bank, providing tools and insights to enhance financial resilience for its customers. Varo's platform also includes features such as spending analysis, real-time budgeting, cash flow forecasts, direct deposits, and online bill payments, all designed to empower users to make informed financial decisions and improve their overall financial well-being.
Swift Health Systems Inc. is a medical device company based in Irvine, California, that specializes in developing innovative orthodontic solutions. The company's flagship product, INBRACE, is an invisible orthodontic system designed to correct malocclusion by being discreetly positioned behind the teeth. INBRACE employs patented self-guiding technology that utilizes light and continuous forces to gently adjust teeth, minimizing discomfort and reducing the frequency of doctor visits. FDA registered, INBRACE aims to make orthodontic treatment more appealing by addressing common patient concerns and facilitating practice growth for clinicians. The system integrates digital treatment planning, computer modeling, and direct digital manufacturing to offer a scalable and personalized approach to a wide range of orthodontic cases, thereby raising the standard of care in the field.
Asher Biotherapeutics, Inc. is a biotechnology company focused on developing immunotherapy drugs for cancer treatment. Founded in 2019 and headquartered in South San Francisco, California, the company aims to create innovative therapeutic solutions to improve patient outcomes in oncology. Asher Bio leverages advanced technologies and research to enhance the effectiveness of immune-based therapies, positioning itself as a key player in the evolving field of cancer treatment.
Neurogastrx, Inc. is a venture-stage biopharmaceutical company focused on developing innovative therapies for gastrointestinal disorders. Established in 2017 and located in Campbell, California, the company aims to address the unmet medical needs associated with functional and motility disorders of the gastrointestinal tract. One of its key products, NG101, is designed to enhance gastric motility while also possessing antiemetic properties. Neurogastrx's specialty therapies target the enteric nervous system, addressing issues related to gut contractions, sensation, and the brain-gut axis, ultimately striving to alleviate the burden of these disorders on patients and the healthcare system.
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.
Private Equity Round in 2021
Circle is a financial technology company that leverages blockchain technology to facilitate the sending, receiving, and investing of cryptocurrency assets globally. Founded in 2013 by Jeremy Allaire and Sean Neville, Circle offers a user-friendly online platform that simplifies money transfers and includes services such as Circle Pay for peer-to-peer payments. In addition, the company provides Circle Invest, allowing users to buy and sell cryptocurrencies, and Circle Trade, which operates a trading desk with a substantial liquidity pool for digital assets, averaging $2 billion in monthly trading volume. With significant backing from investors, including notable firms such as Goldman Sachs and Accel Partners, Circle has established a presence in major cities, including Boston, New York, San Francisco, Dublin, London, and Hong Kong. The company is dedicated to accelerating global crypto innovation and adoption through its various financial services.
Pine Labs Private Limited is a technology company that operates a cloud-based unified point-of-sale (POS) platform designed for merchants across India, Southeast Asia, and the Middle East. The company provides a range of digital payment solutions and merchant commerce services, including Android-based smart POS devices and options for instant equated monthly installment (EMI) payments, loyalty programs, gift cards, and customer analytics. Pine Labs connects financial institutions and consumer brands, facilitating offline and online retail transactions and delivering customer insights for targeted sales strategies. Its platform supports over 350,000 POS terminals in more than 3,700 cities and towns, serving over 100,000 merchants across various sectors such as electronics, food and beverage, and fashion. The company also offers applications like myPlutus, which provides real-time transaction data, and Promozone, which aids in running promotional campaigns. Founded in 1998 and headquartered in Noida, India, Pine Labs has expanded its presence with offices in multiple Indian cities, as well as locations in Kuala Lumpur and Dubai.
Forge Biologics, Inc. is a contract development and manufacturing organization based in Columbus, Ohio, focused on developing and manufacturing gene therapies and genetic medicines. The company specializes in viral vector gene therapies aimed at treating genetic diseases, including a novel approach combining adeno-associated virus (AAV) with umbilical cord transplants for infantile Krabbe disease, a severe neurodegenerative condition. Founded in 2019, Forge Biologics partners with scientists, healthcare professionals, and biotech and pharmaceutical companies to facilitate the transition of gene therapy programs from preclinical development to clinical and commercial-scale production. By providing end-to-end capabilities, the company aims to accelerate the availability of transformative medicines for patients suffering from rare genetic disorders.
Exscientia is applying AI and big data processing to accelerate drug discovery and development. At the forefront of small molecule drug discovery. They are the first company to automate drug design, surpassing conventional human endeavor. Their AI-driven systems actively learn best practice from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters. With better information to hand than any researcher could acquire individually, their knowledge-driven systems design millions of novel, project-specific compounds and pre-assess each for predicted potency, selectivity, ADME and other key criteria. From this, a selection of the best, information-rich compounds are selected for synthesis and assay. With new experimental data generated, the results are integrated and the next design cycle initiated. Rapid design-make-test cycles ensure unparalleled progress towards desired project goals. Exscientia has already delivered exceptional productivity, generating candidates in roughly one-quarter of the time of traditional approaches.
Flywire operates an online payment platform that facilitates both domestic and international transactions, catering primarily to the education and healthcare sectors. The platform enables users, including international students and patients seeking medical care abroad, to make payments in various currencies through familiar online and offline options. By leveraging vertical-specific insights and technology, Flywire streamlines the payment process and enhances operational efficiency while minimizing risks associated with invoicing and payment reconciliation. The company, which was founded in 2009 and is headquartered in Boston, Massachusetts, has established partnerships with TRUE North and Adyen to bolster its offerings. With a significant portion of its revenue generated from the Americas, Flywire continues to expand its services to meet the needs of its diverse clientele.
Century Therapeutics, Inc. is a biotechnology company focused on developing induced pluripotent stem cell (iPSC)-based therapies for cancer treatment. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company aims to create allogeneic living drugs that specifically target both hematologic and solid tumors. By utilizing iPSCs, Century Therapeutics can engineer immune effector cells through multiple rounds of cellular modification, producing master cell banks that can be expanded and differentiated for therapeutic use. Their innovative approach incorporates advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, along with Allo-Evasion technology, which helps prevent rejection by the host immune system. These advancements position Century Therapeutics to enhance the effectiveness and accessibility of cancer treatments.
International Airlines Group is one of the world's largest airline groups. Transporting passengers and cargo generates revenue. It has multiple subsidiaries and attempts to combine leading airlines in Ireland, the United Kingdom, and Spain. It allows airlines to expand global presence and keep individual brands. Staff reports operating segments in a manner consistent with resource-allocation decisions, and are listed as four subsidiaries: British Airways, Iberia, Vueling, and Aer Lingus. Each segment is managed as individual operating companies. Revenue is split between the United Kingdom (roughly one third), Spain, the United States, and the rest of the world.
LGI Homes, Inc. designs, constructs, and sells homes in the United States. It offers entry-level homes, such as detached and attached homes, and move-up homes under the LGI Homes brand name; and luxury series homes under the Terrata Homes brand name. As of March 31, 2020, it owned 113 communities. The company serves in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, South Carolina, Washington, Tennessee, Minnesota, Oklahoma, Alabama, California, Oregon, Nevada, and West Virginia. LGI Homes, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.